ESR1 and neoplasm: PI3K and Akt can phosphorylate ERα at Ser167, activating the ER in the absence of estradiol, as such tumor cells can circumnavigate hormone therapy, adapting and undergoing estrogen-dependent growth (Dong et al., 2021).